We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to contact MHRA for specific services or enquiries.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Information about the risks of taking valproate medicines during pregnancy.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
Guidance on the Ionising Radiation (Medical Exposure) Regulations 2017 for employers and health professionals who carry out medical radiological procedures.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
You must get permission to export certain drugs and medicines.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
How to conform with the legal requirements for placing medical devices on the market.
Information on when software applications are considered to be a medical device and how they are regulated.
The eMIT provides information about prices and usage for generic drugs and pharmaceutical products.
This document provides guidance on the data integrity expectations that should be considered by organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Who can supply and or administer specific medicines to patients without a doctor under a PGD and which medicines can be administered.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
A list of herbal ingredients which are banned or restricted for unlicensed medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).